The “mission” of the European Commission for the 2021 – 2017 Programming Period is to engage citizens in a continuous…
REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients
The European Code of Cancer Practice: how to implement good clinical practices
The European Cancer Organization recently launched the Code for Cancer Practice. The European Code of Cancer Practice (The Code) is…
Challenge Cancer Intergroup: the first and only EU Parliamentary Intergroup on cancer
On Wednesday 1 July 2020, the launch of the European Parliament Challenge Cancer Intergroup took place via webinar. The event…
Published by the European Cancer League the Europe’s Beating Cancer Plan Position Paper 2020
The last March 2020, the European Cancer Leagues (ECL) has published the Europe’s Beating Cancer Plan Position Paper 2020 –…
1,4 fewer screenings for cancers in the first 5 months of 2020 as a result of the outbreak
The Italian Association of Medical Oncology reported that as a result of the Covid-19 pandemic, in the first 5 months…
Interview with Fiorella Guadagni, Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele Pisana
Can you briefly describe the Institute? The Scientific Institute for Research, Hospitalization and Health Care (IRCCS) San Raffaele Pisana –…
Launch of the EU REVERT project – Targeted Therapy for Cororectal Cancer Patients
“Revert (Targeted Therapy for Cororectal Cancer Patients)” is a European Project funded by the European Union’s Horizon 2020 research and…
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848098”.